BACKGROUND: Ghrelin, the only identified circulating orexigenic signal, is unique in structure in which a specific acyl-modification of its third serine occurs. This acylation is necessary for ghrelin to bind to its receptor and to exert its biologic activity, which is catalyzed by ghrelin O-acyltransferase (GOAT). Although ghrelin is mainly secreted from gastric X/A like endocrine cells, it is also expressed in pancreatic islet cells and regulates insulin secretion. In this study, we examined the expression and regulation of GOAT in pancreas. METHODS: GOAT mRNA and immunoreactivity were examined in pancreatic islets and INS-1 cells by RT-PCR and immunofluorescent staining or Western blotting. RESULTS: Insulin inhibits the expression of GOAT mRNA and GOAT promoter activity in a dose and time-dependent manner. The mammalian target of rapamycin (mTOR) is activated by insulin. Blocking mTOR signaling by either rapamycin or overexpression of its negative regulator tuberous sclerosis complex 1 (TSC1) or TSC2 attenuates the inhibitory effect of insulin on the transcription and translation of GOAT. CONCLUSION: Our study suggests that GOAT is present in pancreatic islet cells and that insulin inhibits the expression of GOAT via the mediation of mTOR signaling.
BACKGROUND:Ghrelin, the only identified circulating orexigenic signal, is unique in structure in which a specific acyl-modification of its third serine occurs. This acylation is necessary for ghrelin to bind to its receptor and to exert its biologic activity, which is catalyzed by ghrelin O-acyltransferase (GOAT). Although ghrelin is mainly secreted from gastric X/A like endocrine cells, it is also expressed in pancreatic islet cells and regulates insulin secretion. In this study, we examined the expression and regulation of GOAT in pancreas. METHODS:GOAT mRNA and immunoreactivity were examined in pancreatic islets and INS-1 cells by RT-PCR and immunofluorescent staining or Western blotting. RESULTS:Insulin inhibits the expression of GOAT mRNA and GOAT promoter activity in a dose and time-dependent manner. The mammalian target of rapamycin (mTOR) is activated by insulin. Blocking mTOR signaling by either rapamycin or overexpression of its negative regulator tuberous sclerosis complex 1 (TSC1) or TSC2 attenuates the inhibitory effect of insulin on the transcription and translation of GOAT. CONCLUSION: Our study suggests that GOAT is present in pancreatic islet cells and that insulin inhibits the expression of GOAT via the mediation of mTOR signaling.
Authors: L Cornelius Bollheimer; Christian E Wrede; Felix Rockmann; Iris Ottinger; Jürgen Schölmerich; Roland Buettner Journal: Biochem Biophys Res Commun Date: 2005-04-29 Impact factor: 3.575
Authors: G Xu; Z Wang; Y Li; Z Li; H Tang; J Zhao; X Xiang; L Ding; L Ma; F Yuan; J Fei; W Wang; N Wang; Y Guan; C Tang; M Mulholland; W Zhang Journal: Diabetologia Date: 2012-03-03 Impact factor: 10.122
Authors: Jenny Tong; Ronald L Prigeon; Harold W Davis; Martin Bidlingmaier; Matthias H Tschöp; David D'Alessio Journal: J Clin Endocrinol Metab Date: 2013-04-15 Impact factor: 5.958
Authors: A Benso; E Gramaglia; I Olivetti; M Tomelini; S Belcastro; E Calvi; A Dotta; D St-Pierre; E Ghigo; F Broglio Journal: Endocrine Date: 2014-07-11 Impact factor: 3.633
Authors: A Rodríguez; J Gómez-Ambrosi; V Catalán; F Rotellar; V Valentí; C Silva; C Mugueta; M R Pulido; R Vázquez; J Salvador; M M Malagón; I Colina; G Frühbeck Journal: Diabetologia Date: 2012-08-07 Impact factor: 10.122
Authors: Alonso Camacho-Ramírez; María Ángeles Mayo-Ossorio; José Manuel Pacheco-García; David Almorza-Gomar; Antonio Ribelles-García; Ana Belmonte-Núñez; J Arturo Prada-Oliveira; Gonzalo M Pérez-Arana Journal: Histol Histopathol Date: 2020-01-17 Impact factor: 2.303